Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis

Disease Trajectories in Atopic Dermatitis and Psoriasis

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The clinical study investigates the long-term course of disease in patients with chronic inflammatory skin diseases (atopic eczema and psoriasis) and the impact of tarheted therapies on the clinical and molecular level. For this purpose, patients are asked to take part in regular examinations and data collections, and to donate biomaterials (blood, skin biopsies, skin swabs, tape strips, stool samples). Blood samples are used to analyze inflammation messengers. Punch biopsies from lesional and non-lesional skin areas are used to analyze gene expression. Tape strips are pieces of transparent adhesive tapes to strip off most of the horny layer that will be used to examine mRNA and protein expression. The skin smears are superficial smears of three areas of skin with cotton swabs, which are used to examine bacteria on the skin. Overall, the study will help to monitor the disease course clinically and on the molecular level in participating patients for at least ten years and to collect information about the impact of various external factors including treatments. The study has no effect on the therapies of the disease, it serves only the accompanying data collection

Who May Be Eligible (Plain English)

Who May Qualify: - Patients with a clinical diagnosis of atopic dermatitis, psoriasis or autoimmune skin disease - Written willing to sign a consent form obtained from the subject Who Should NOT Join This Trial: - Patients who decline participation In patients\<18 years of age no biopsies will be taken Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Patients with a clinical diagnosis of atopic dermatitis, psoriasis or autoimmune skin disease * Written informed consent obtained from the subject Exclusion Criteria: * Patients who decline participation In patients\<18 years of age no biopsies will be taken

Treatments Being Tested

OTHER

Biosampling for molecular analysis

Observational study with no therapeutic intervention. Biosampling for molecular analysis

Locations (1)

Department of Dermatology, University Hospital Schleswig Holstein, Campus Kiel
Kiel, Germany